Shimadzu Corporation, Eisai Co., Ltd., Oita University, and Usuki City Medical Association have demonstrated the utility of blood biomarkers in predicting the accumulation of amyloid beta (Aβ)(1) in ...

AD is a neurodegenerative disease characterized by neuronal loss in the cerebral cortex and the formation of extracellular ...

Derick Han Associate Professor of Biochemistry and Pharmacology Claremont, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- One of ...

Experts explored the latest trends, approvals, and pipeline developments in cell and gene therapies, rare disease, immunology ...

综上所述，香菇多糖在体外和体内均表现出对Aβ和α-syn纤维聚集的抑制作用，并能够显著缓解其引起的神经毒性和行为缺陷。这些结果表明，香菇多糖可能作为一种潜在的治疗药物用于AD和PD的防治，这一研究为天然多糖类物质在神经退行性疾病中的应用提供了新的思路 ...

A research team at the Institute of Neurosciences of the University of Barcelona (UBneuro) has led a study describing a new ...

A research team at the Institute of Neurosciences of the University of Barcelona (UBneuro) has led a study describing a new ...

A research team at the Institute of Neurosciences of the University of Barcelona (UBneuro) has led a study describing a new ...

The establishment of glucose-regulated insulin secretion from pancreatic β-cells requires multiple ... of insulin production and secretion. Amyloid-like proteins are central to age-related ...

AstraZeneca has clearly made the rare disease transthyretin amyloidosis (ATTR) a key component of its rare disease pipeline, licensing a second drug candidate in the space of a couple of months.